Results
1 -
10 of
466
(Click
here to explore results)
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 5 Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Ramón Cacabelos, Juan Carlos Carril, Oscar Teijido
, 2017
, Pages 75-141
- Metal-based Anticancer Agents, CHAPTER 1 Enhancing the Therapeutic Potential of Platinum-based Anticancer Agents by Incorporating Clinically Approved Drugs as Ligands. Reece G. Kenny, Celine J. Marmion
, 2019
, Pages 1-30
- Epigenetics for Drug Discovery, CHAPTER 5 Targeting Histone Acetylation. Daniel Vitt, Roland Baumgartner, Hella Kohlhof
, 2016
, Pages 96-126
- Macrocycles in Drug Discovery, CHAPTER 4 Macrocyclic Inhibitors of Zinc-dependent Histone Deacetylases (HDACs). A. Ganesan
, 2015
, Pages 109-140
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 21 HDAC Inhibitors: A New Avenue in Anti-Aging Medicine. E. G. Pasyukova, A. M. Vaiserman
, 2017
, Pages 514-534
- New Frontiers in Chemical Biology: Enabling Drug Discovery, Chapter 5 Chemical Biology of Histone Modifications. Nathan R. Rose, Christopher J. Schofield, Tom D. Heightman
, 2011
, Pages 151-203
- Metal-based Anticancer Agents, CHAPTER 3 Iron Compounds as Anticancer Agents. Anne Vessieres
, 2019
, Pages 62-90
- Epigenetics for Drug Discovery, CHAPTER 9 Who will Benefit from Epigenetic Drugs?. Dominique Verhelle, David J. Shields
, 2016
, Pages 230-248
- Hazardous Reagent Substitution: A Pharmaceutical Perspective, Chapter 8 New Directions from Academia. Manavi Yadav, Sriparna Dutta, Rakesh Kumar Sharma
, 2018
, Pages 130-167
- Polyamine Drug Discovery, Chapter 10 The Design and Development of Polyamine-Based Analogs with Epigenetic Targets. Yi Huang, Laurence J. Marton, Patrick M. Woster
, 2012
, Pages 238-256